Get started
GUANGZHOU LBP MEDICINE SCIENCE & TEGG

GUANGZHOU LBP MEDICINE SCIENCE & TE

40.23CNYD
−2.00−4.74%
At close at Mar 7, 09:09 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

688393 fundamentals

Key facts

Market capitalization‪3.76 B‬CNY
Dividend yield (indicated)0.37%
Price to earnings Ratio (TTM)181.01
Basic EPS (TTM)0.24CNY
Founded2005
Employees (FY)—
CEOXiang Ting Cai
Websitegzlbp.com
About

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and instruments. Its products include cytological, immunohistochemical, and molecular diagnostic reagents and instruments. The company was founded by Xiang Ting Cai on July 6, 2005 and is headquartered in Guangzhou, China.

Ownership
‪‪93.57 M‬‬
Free Float shares
‪‪84.78 M‬‬ (90.61%)
Closely held shares
‪‪8.78 M‬‬ (9.39%)
Free Float shares
‪‪84.78 M‬‬ (90.61%)
Closely held shares
‪‪8.78 M‬‬ (9.39%)
Capital structure
Market cap
‪‪3.76 B‬‬
Enterprise value
‪‪3.76 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪3.76 B‬‬
Price to earning ratio (P/E)
181.01x
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
181.01x
Price to sales ratio (P/S)
—
Valuation ratios
‪0.00‬
‪1.50‬
‪3.00‬
‪4.50‬
‪6.00‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪16.00‬
‪32.00‬
‪48.00‬
‪64.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−4%‬
‪0%‬
‪4%‬
‪8%‬
‪12%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−50.00 M‬‬
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−140.00 M‬‬
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−140.00 M‬‬
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Self-Produced Products
Purchased Products
Service
Other
By country
Period: 2024
China
Overseas

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
0.37%
Last payment
0.15
Last ex-date
May 29, 2024
Dividend history
‪0.60%‬
‪0.68%‬
‪0.76%‬
‪0.84%‬
‪0.92%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.08‬
‪0.16‬
‪0.24‬
‪0.32‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−70.00 M‬‬
‪‪−35.00 M‬‬
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.